New syringe design aims to simplify eye injection for blinding diseases
NCT ID NCT07550504
First seen Apr 29, 2026 · Last updated May 19, 2026 · Updated 4 times
Summary
This study tested whether a pre-filled syringe of the drug SB11 is easy for eye doctors to use. Thirty people with wet age-related macular degeneration or related eye swelling received one injection. The main goal was to see if doctors could successfully complete all 12 steps to prepare and give the injection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIC CHOROIDAL NEOVASCULARIZATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research site
Krakow, Poland
-
Research site
Olsztyn, Poland
Conditions
Explore the condition pages connected to this study.